Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

par prism | Nov 8, 2022 | Publications

Yoann Pradat, Julien Viot, Konstantin Gunbin, Andrey Yurchenko, Luigi Cerbone, Marc Deloger, Guillaume Grisay, Loic Verlingue, Véronique Scott, Ismael Padioleau, Leonardo Panunzi, Stefan Michiels,...

Search

Recent Posts

  • Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
  • Bodywide ecological interventions on cancer
  • Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
  • Genomics to select treatment for patients with metastatic breast cancer
  • Save the date : Toward implementation of precision medicine, a multistakeholder workshop

Recent Comments